72 results
8-K
EX-99.1
RCEL
AVITA Medical Inc
22 Feb 24
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
4:02pm
the third quarter of 2025
Fourth Quarter 2023 Financial Results
Our commercial revenue, which excludes Biomedical Advanced Research and Development … of funding from the Biomedical Advanced Research and Development Authority, under the Assistant Secretary for Preparedness and Response, within the U.S
8-K
EX-99.1
RCEL
AVITA Medical Inc
9 Nov 23
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
4:09pm
Our commercial revenue, which excludes Biomedical Advanced Research and Development Authority (BARDA) revenue, increased by 51% to $13.5 million … million in cash, cash equivalents, and marketable securities.
BARDA income consisted of funding from the Biomedical Advanced Research
8-K
EX-10.1
RCEL
AVITA Medical Inc
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
, customer and prospective customer lists and information, and supplier and prospective supplier lists and information, research and development … combination of research, development, manufacture, import, use, sale, importation, storage, labeling, marketing, promotion, supply, distribution, testing
424B5
sb3ul0j
18 Oct 23
Prospectus supplement for primary offering
9:04am
8-K
EX-99.1
phtny7
10 Aug 23
AVITA Medical Reports Second Quarter Financial Results
4:05pm
8-K
EX-99.1
d8x5ocun1iry0o1 fnc
12 May 23
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
4:01pm
8-K
EX-99.2
lca ckieyeeb
12 May 23
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
4:01pm
424B2
20lgqe76l
25 Apr 23
Prospectus for primary offering
5:28pm
8-K
EX-99.1
alow6
14 Nov 22
AVITA Medical Reports Third Quarter 2022 Financial Results
6:18am
8-K
EX-99.1
tngawle
9 Nov 22
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
4:54pm
8-K
EX-99.1
tdtlsyhsw4q
12 Aug 22
AVITA Medical Reports Second Quarter 2022 Financial Results
1:21pm
8-K
EX-99.1
ntkgpxvq9f149qx14d
17 May 22
AVITA Medical Reports First Quarter 2022 Financial Results
4:03pm